CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-10-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $440.35 | $6.4M | 0 |
| 2025-10-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-10-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $440.35 | $3.5M | 0 |
| 2025-10-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 85,125 | ||
| 2025-10-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 9,625 | ||
| 2025-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $437.53 | $438K | 3,130 |
| 2025-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,000 | $441.40 | $1.3M | 130 |
| 2025-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 190,000 | ||
| 2025-10-10 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $442.96 | $443K | 3,130 |
| 2025-10-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,000 | $445.28 | $1.3M | 130 |
| 2025-10-10 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 194,000 | ||
| 2025-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $445.25 | $445K | 3,130 |
| 2025-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $449.58 | $899K | 1,130 |
| 2025-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $451.24 | $451K | 130 |
| 2025-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 198,000 | ||
| 2025-10-08 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
Page 193 of 214 · 4,273 trades